ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,159Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 96

$765K Total Retail Price of All Prescriptions

Rank: 17 out of 96

535 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,160 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 390 326 1 1
AMLODIPINE BESYLATE 386 368 2 2
NAMENDA 383 382 3 11
LEVOTHYROXINE SODIUM 369 346 4 3
FUROSEMIDE 339 294 5 4
OMEPRAZOLE 329 247 6 5
METOPROLOL TARTRATE 296 266 7 7
LISINOPRIL 279 261 8 10
WARFARIN SODIUM 255 220 9 6
DONEPEZIL HCL 224 224 10 8
PANTOPRAZOLE SODIUM 207 180 11 44
METOPROLOL SUCCINATE 198 191 12 9
HYDROCHLOROTHIAZIDE 186 176 13 16
CITALOPRAM HBR 166 155 14 25
SERTRALINE HCL 155 138 15 15
FAMOTIDINE 148 126 16 21
ISOSORBIDE MONONITRATE ER 148 127 16 60
RISPERIDONE 140 123 18 31
ESCITALOPRAM OXALATE 138 113 19 24
TRAZODONE HCL 136 114 20 38
METFORMIN HCL 133 112 21 13
POTASSIUM CHLORIDE 128 103 22 19
LOSARTAN POTASSIUM 114 92 23 23
QUETIAPINE FUMARATE 107 67 24 32
TAMSULOSIN HCL 92 89 25 29
POLYETHYLENE GLYCOL 3350 89 77 26 53
CLOPIDOGREL 86 76 27 27
HYDROCODONE-ACETAMINOPHEN 85 67 S3 28 52
NEXIUM 84 55 29 40
LIDODERM 83 73 30 45
LEVETIRACETAM 82 45 31 61
ZOLPIDEM TARTRATE 82 64 31 18
FLUTICASONE PROPIONATE 81 34 33 55
EXELON 79 79 34 47
DIGOXIN 77 70 35 34
CARVEDILOL 77 58 35 22
ATORVASTATIN CALCIUM 76 76 37 12
GABAPENTIN 73 64 38 20
DIVALPROEX SODIUM 69 38 39 41
HYDRALAZINE HCL 67 63 40 79
OXYCODONE HCL 66 28 S2 41 95
FINASTERIDE 65 59 42 85
RANITIDINE HCL 64 55 43 75
OXYCONTIN 64 42 S2 43 118
PRAVASTATIN SODIUM 63 55 45 33
CARBIDOPA-LEVODOPA 62 62 46 48
LACTULOSE 62 37 46 37
MORPHINE SULFATE ER 62 35 S2 46 186
SINGULAIR 62 38 46 78
BUSPIRONE HCL 61 52 50 116
OXYCODONE-ACETAMINOPHEN 60 43 S2 51 26
JANUVIA 58 55 52 49
KLOR-CON M20 58 57 52 91
TOPIRAMATE 57 0 54 252
DETROL LA 56 49 55 256
ENALAPRIL MALEATE 55 54 56 28
PAROXETINE HCL 55 49 56 66
RAMIPRIL 55 55 56 69
PLAVIX 54 49 59 42
CLONIDINE HCL 51 47 60 74
MIRTAZAPINE 50 41 61 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.